Ucb Biopharma Srl

This study tested the drug lacosamide in newborns (up to 28 days old) who were still having seizures despite other treatments. The goal was to see if lacosamide could reduce seizure activity measured on brain wave tests. The trial was stopped early, and only 29 babies took part.

This study tested a single dose of a new drug, UCB3101, in 167 healthy adults to see if it is safe and how the body processes it. Participants were randomly assigned to receive either the drug or a placebo, and neither they nor the study doctors knew who got which. The study was …